In a patient on amiodarone who has distal burning pain, numbness, paresthesias, and gait instability, but also shows true spasticity, a positive Babinski sign, an upper‑motor‑neuron pattern, and bowel/bladder dysfunction, can amiodarone‑induced peripheral neuropathy explain these central signs, or what further evaluation is needed?

Amiodarone Cannot Explain Upper Motor Neuron Signs—Urgent Neuroimaging Required

You are correct: amiodarone-induced peripheral neuropathy cannot explain true spasticity, Babinski signs, upper motor neuron patterns, or bowel/bladder dysfunction from cord involvement. These findings mandate immediate evaluation for a separate central nervous system pathology, most likely spinal cord disease.

Why Amiodarone Toxicity Is Insufficient

Documented Neurologic Effects of Amiodarone

Amiodarone's neurologic toxicity is well-characterized and strictly peripheral in nature:

• Peripheral neuropathy occurs at 0.3% annually and manifests as ataxia, paresthesias, and tremor 1
• The neuropathy is typically a mixed sensorimotor polyneuropathy with distal predominance, showing demyelinating features on nerve conduction studies 2, 3
• Neurologic side effects include tremor (most common), ataxia, and peripheral neuropathy—but notably without long-tract signs 4
• Pathologically, amiodarone causes lysosomal inclusions in Schwann cells and axonal degeneration, confirming a peripheral nerve process 2, 3

What Amiodarone Does NOT Cause

The guideline literature explicitly states that amiodarone neurotoxicity occurs "without nystagmus, dizziness, encephalopathy, or long-tract signs" 4. Your patient's findings are incompatible with amiodarone toxicity alone:

• True spasticity with velocity-dependent resistance and clasp-knife phenomenon indicates corticospinal tract dysfunction 5
• Babinski signs are pathognomonic for upper motor neuron lesions 5
• Bowel/bladder dysfunction from cord involvement reflects sacral nerve root or conus medullaris pathology, not peripheral neuropathy 6

Required Evaluation

Immediate Neuroimaging

Obtain urgent MRI of the entire spine with and without contrast to evaluate for:

• Compressive myelopathy (cervical or thoracic stenosis, disc herniation, tumor)
• Inflammatory myelitis (transverse myelitis, multiple sclerosis)
• Vascular myelopathy (spinal cord infarction, dural arteriovenous fistula)
• Structural lesions (syrinx, tumor, abscess)

The combination of upper motor neuron signs with bowel/bladder dysfunction localizes to the spinal cord and requires imaging before any other diagnostic consideration 6.

Additional Diagnostic Testing

• Lumbar puncture (if imaging shows no contraindication) to evaluate for inflammatory, infectious, or neoplastic processes
• Vitamin B12 with metabolites (methylmalonic acid, homocysteine) as B12 deficiency can cause subacute combined degeneration with both peripheral neuropathy and myelopathy 7
• Serum copper and ceruloplasmin to exclude copper deficiency myeloneuropathy
• HIV testing if risk factors present, as HIV-associated myelopathy can present similarly

The Autonomic Dysfunction Caveat

You correctly note that autonomic features (bowel/bladder dysfunction) could theoretically be purely peripheral, especially in a diabetic patient 1. However:

• Peripheral autonomic neuropathy typically presents with orthostatic hypotension, gastroparesis, and erectile dysfunction before bowel/bladder symptoms 1
• When bowel/bladder dysfunction occurs in conjunction with spasticity and Babinski signs, the localization is unequivocally central (spinal cord) 6
• Diabetic autonomic neuropathy affects postganglionic sudomotor and cardiovagal function but does not produce upper motor neuron signs 1

Clinical Pitfalls to Avoid

Do Not Attribute Everything to Amiodarone

While amiodarone can cause distal burning pain, numbness, and paresthesias 1, 4, 2, the presence of upper motor neuron signs indicates a second, concurrent neurologic process. Patients on amiodarone can develop unrelated spinal cord pathology.

Do Not Delay Imaging for Electrodiagnostic Studies

Nerve conduction studies and EMG can confirm peripheral neuropathy but will not detect spinal cord lesions. The upper motor neuron findings take diagnostic priority and require immediate anatomic imaging.

Consider Dual Pathology

This patient likely has both:

1. Amiodarone-induced peripheral neuropathy (explaining distal sensory symptoms)
2. A separate myelopathy (explaining spasticity, Babinski signs, and bowel/bladder dysfunction)

The coexistence of peripheral and central pathology is not uncommon, particularly in patients with diabetes who may have both diabetic neuropathy and cervical/thoracic stenosis 7.

Management Algorithm

1. Discontinue or reduce amiodarone if cardiac status permits, as peripheral neuropathy is dose-related and reversible 1, 4, 2
2. Obtain urgent spine MRI (same day if progressive weakness or acute urinary retention)
3. Consult neurology for evaluation of myelopathy
4. Treat the underlying spinal pathology based on imaging findings (surgical decompression for stenosis, steroids for inflammatory myelitis, etc.)
5. Monitor for improvement in peripheral neuropathy symptoms after amiodarone withdrawal, which typically occurs within 2 days to 4 weeks 4